Female patients suffering from MESO (Figure 8F, p = 0.034) and SARC (Figure 8G, p = 0.009) had higher MXD3 expression than males, but female patients suffering from BLCA (Figure 8D, p = 0.037) and HNSC (Figure 8E, p = 0.014) had lower expression. Here, MXD3 is linked to bladder transitional cell carcinoma.